Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "Sungwook Kang"
Filter
Filter
Article type
Keywords
Publication year
Authors
Original Article
Thyroid
Cost-of-Illness Trends Associated with Thyroid Disease in Korea
Kyung-Rae Hyun, Sungwook Kang, Sunmi Lee
Endocrinol Metab. 2014;29(3):257-269.   Published online September 25, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.3.257
  • 3,255 View
  • 30 Download
  • 8 Citations
AbstractAbstract PDFPubReader   
Background

The purpose of this study is to analyze the scale of and trends associated with the cost-of-illness of thyroid disease in Korea at 2-year intervals during the last 10 years for which data are available.

Methods

Cost-of-illness was estimated in terms of direct and indirect costs. Direct costs include direct medical costs due to hospitalization, outpatient and pharmacy sectors, transportation, and care-giver costs. Indirect costs include future income loss due to premature death and loss of productivity as a result of absence from work.

Results

The cost-of-illness of thyroid disease in Korea was estimated at 224.2 billion won in 2002, 303.4 billion won in 2004, 400.3 billion won in 2006, 570.4 billion won in 2008, and 762.2 billion won in 2010. For example, the cost-of-illness of thyroid disease in 2010 was 3.4 times greater compared to 2002. The direct cost of the total cost-of-illness was 69.7%, which accounted for the highest proportion of costs. Cost-of-illness for individuals between the ages of 30 and 50 accounted for the greatest share of costs.

Conclusion

The cost-of-illness of thyroid disease was relatively large in economically active age groups, and demonstrated a very rapid growth rate compared to other major diseases in Korea. Therefore, we suggest nationwide recognition of the importance of prevention and management of thyroid disease and prioritization of the management of thyroid disease among current and future health promotion policies in Korea.

Citations

Citations to this article as recorded by  
  • Cancer and Mortality Risks of Graves’ Disease in South Korea Based on National Data from 2010 to 2019
    Young Ju Choi, Kyungdo Han, Won Kyoung Cho, Min Ho Jung, Byung-Kyu Suh
    Clinical Epidemiology.2023; Volume 15: 535.     CrossRef
  • Who loses more? Identifying the relationship between hospitalization and income loss: prediction of hospitalization duration and differences of gender and employment status
    Minsung Sohn, Daseul Moon, Patricia O’Campo, Carles Muntaner, Haejoo Chung
    BMC Public Health.2022;[Epub]     CrossRef
  • The importance and effectiveness of nutritional counselling in patients with autoimmune thyroid diseases in Poland
    Ewa Czubek, Klaudia Alcer, Mirjana Varjacic, Piotr Romaniuk
    Cost Effectiveness and Resource Allocation.2022;[Epub]     CrossRef
  • Socioeconomic Costs of Dementia Based on Utilization of Health Care and Long-Term-Care Services: A Retrospective Cohort Study
    Eun-Jeong Han, JungSuk Lee, Eunhee Cho, Hyejin Kim
    International Journal of Environmental Research and Public Health.2021; 18(2): 376.     CrossRef
  • Triennial Report ofEndocrinology and Metabolism, 2015 to 2017
    Eun-Jung Rhee, Hey Yeon Jang, Won-Young Lee
    Endocrinology and Metabolism.2018; 33(2): 195.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
  • Cost-of-Illness Trend of Thyroid Gland Disease in Korea
    Jae Hoon Chung
    Endocrinology and Metabolism.2014; 29(3): 248.     CrossRef
  • Letter: Insufficient Experience in Thyroid Fine-Needle Aspiration Leads to Misdiagnosis of Thyroid Cancer (Endocrinol Metab2014;29:293-9, Jung Il Son et al.)
    Hyon-Seung Yi, Sihoon Lee
    Endocrinology and Metabolism.2014; 29(4): 590.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism